SCHEMBL27486001

SCHEMBL27486001

Cc1cc(C)cc(C(=O)Nc2ncc(Cc3ccncc3)c3ccccc23)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.52
▸ MAPT P10636 3/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ TDP1 Q9NUW8 2/20 0.48
▸ PDGFRB P09619 2/20 0.46
▸ KIT P10721 2/20 0.46
▸ FLT1 P17948 2/20 0.46
▸ KDR P35968 2/20 0.46
▸ POLB P06746 2/20 0.44
▸ NAMPT P43490 5/20 0.42
▸ LMNA P02545 3/20 0.41
▸ HPGD P15428 2/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ NT5E P21589 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ PTGDR2 Q9Y5Y4 1/20 0.40
▸ MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27483911 0.83 PDGFRB (0.47) MAPTALDH1A1PDGFRBKITFLT1
SCHEMBL3152355 0.81 FLT1 (0.64) PDGFRBKITFLT1KDRPOLB
SCHEMBL13955641 0.76 PDGFRB (0.45) GAAMAPTALDH1A1TDP1PDGFRB
SCHEMBL13955450 0.74 FLT1 (0.48) MAPTPDGFRBKITFLT1KDR
SCHEMBL13955448 0.72 FLT1 (0.47) GAAMAPTALDH1A1PDGFRBKIT
SCHEMBL27511538 0.71 FLT1 (0.60) GAAMAPTALDH1A1TDP1PDGFRB
SCHEMBL2203269 0.71 FLT1 (0.46) MAPTPDGFRBKITFLT1KDR
SCHEMBL13955411 0.71 KDR (0.48) MAPTPDGFRBKITFLT1KDR
SCHEMBL13955484 0.70 KDR (0.50) PDGFRBKITFLT1KDRMEN1
SCHEMBL13955593 0.70 FLT1 (0.43) MAPTPDGFRBKITFLT1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1319100-A Isoquinoline derivatives having angiogenesis inhibitory activity NOVARTIS AG (CH) 2001-10-24 — — CN claimed
CN-105579044-A Use of dianhydrogalactitol and analogs and derivatives thereof for treating recurrent malignant glioma or progressive secondary brain tumor DEL MAR PHARMACEUTICALS 2016-05-11 — — CN disclosed
CN-1152031-C Isoquinoline derivatives having angiogenesis inhibitory activity ��˹��ŵ�� 2004-06-02 — — CN disclosed
Send feedback